The Surge In Vitamin D Therapy Market Fueled By The Rising Prevalence Of Malnutrition Is Supporting Development Across The Vitamin D Therapy Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Vitamin D Therapy Market During The 2026–2030 Period?

The vitamin d therapy market has experienced swift expansion recently. It is projected to increase from $3.24 billion in 2025 to $3.67 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.1%. This historical growth can be primarily attributed to the escalating occurrence of vitamin d deficiency, heightened consumer understanding regarding bone health, the proliferation of over-the-counter vitamin d supplements, an expanding elderly demographic, and the wider adoption of fortified foods and beverages.

The vitamin d therapy market is projected for significant expansion over the coming years. By 2030, it is anticipated to reach $6.05 billion, demonstrating a compound annual growth rate (CAGR) of 13.4%. This growth during the forecast period is primarily driven by factors such as advancements in personalized nutrition, the incorporation of vitamin d into functional foods, the expansion of preventive healthcare, increasing government efforts for micronutrient supplementation, and the growing focus on chronic disease management. Key trends expected within this period encompass personalized vitamin d supplementation, the integration of fortified foods and beverages, heightened awareness of vitamin d deficiency, a stronger emphasis on bone health and immunity, and an increase in home healthcare solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8810&type=smp

What Market Drivers Are Helping Shape The Vitamin D Therapy Market Expansion?

The growing number of malnutrition cases is set to fuel the expansion of the vitamin D therapy market. Malnutrition describes conditions where nutrient intake is either insufficient or excessive, where essential nutrients are out of balance, or where nutrient utilization is impaired. A high prevalence of vitamin D deficiency is observed in hospitalized malnourished patients, and this deficiency is linked to increased long-term mortality, especially when individuals do not receive vitamin D treatment. Consequently, the rising incidence of malnutrition cases generates a need for vitamin D therapy. For example, in August 2025, UNICEF, a US-based United Nations agency, reported that over 251.7 million children under 5 were screened for wasting across 64 countries, surpassing the 200 million target; among these, more than 9.3 million children with severe wasting were admitted for vital treatment. Thus, the increasing occurrence of malnutrition cases is propelling the growth of the vitamin D therapy market. The increasing prevalence of chronic diseases is projected to drive the demand for the vitamin D therapy market. A chronic disease is a condition that persists over time, progresses, and typically worsens without lifestyle modifications. Examples include Alzheimer’s disease, rheumatoid arthritis, Parkinson’s disease, and various cancers. Vitamin D therapy plays a vital role in the management of chronic conditions by addressing associated complications and supporting overall health. Numerous studies have indicated a link between vitamin D deficiency and an elevated risk of chronic ailments such as cardiovascular diseases, diabetes, and specific cancers. Adequate vitamin D levels contribute to the regulation of the immune system, cardiovascular well-being, and metabolic function. Individuals suffering from chronic diseases frequently display lower vitamin D levels, and supplementation is recognized as a valuable addition to their treatment. For instance, in May 2024, according to the National Cancer Institute (NCI), a US-based federal government’s principal agency for cancer research and training, an estimated 2,001,140 new cases of cancer will be diagnosed in the United States in 2024, and 611,720 people will die from the disease. Prostate, lung, and colorectal cancers are expected to account for 48% of all cancers diagnosed in men in 2024. For women, breast, lung, and colorectal cancers are the three most common, anticipated to comprise 51% of all new cancer diagnoses in women in 2024. The population of cancer survivors is forecasted to reach 22.5 million by 2032. Therefore, the growing incidence of chronic diseases is fostering the expansion of the vitamin D therapy market.

Which Segment Groups Define The Vitamin D Therapy Market Landscape?

The vitamin d therapy market covered in this report is segmented –

1) By Administration: Oral, Parenteral

2) By Purchasing: OTC Drugs, Prescription Drugs

3) By Age Group: Children, Adults, Senior Adults

4) By Application: Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders

Subsegments:

1) By Oral: Vitamin D3 Supplements (Cholecalciferol), Vitamin D2 Supplements (Ergocalciferol), Vitamin D Fortified Foods And Beverages

2) By Parenteral: Injectable Vitamin D3 (Cholecalciferol), Injectable Vitamin D2 (Ergocalciferol), Intravenous Vitamin D Preparations

What Trends Are Affecting The Growth Of The Vitamin D Therapy Market?

Key companies operating in the vitamin D therapy market are engaging in partnerships to strengthen their presence. A business strategic partnership signifies a structured collaboration between two or more commercial entities, typically formalized through one or more business agreements or contracts. For instance, in July 2024, Catalyst Pharmaceuticals, Inc. Ltd., a US-based pharmaceutical company, entered into a License, Supply, and Commercialization Agreement with Kye Pharmaceuticals Inc, a Canada-based pharmaceutical company, which granted Kye the exclusive Canadian commercial rights for AGAMREE (vamorolone). Vamorolone is used for treating Duchenne muscular dystrophy (DMD), a condition resulting from vitamin deficiency.

Which Companies Form The Competitive Landscape Of The Vitamin D Therapy Market?

Major companies operating in the vitamin d therapy market are Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Pfizer Inc., Merck & Co Inc., Torrent Pharmaceuticals Ltd., Novartis International AG, Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Biotics Research Corporation, Solvay Pharma India Pvt. Ltd., Forgo Pharmaceuticals Ltd., Mankind Pharmaceuticals Pvt. Ltd., Cipla Ltd., Ortho Molecular Products, Zhejiang Garden Biochemical High-tech Co. Ltd., Glenmark Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Biocare Medical LLC, Mitsubishi Chemical Group, Zydus Cadila, DSM Nutritional Products AG, BASF SE, Fermenta Biotech Ltd., Taizhou Hisound Pharmaceutical Co. Ltd.

Access The Complete Vitamin D Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report

Which Area Represents The Largest Portion Of The Vitamin D Therapy Market?

North America was the largest region in the vitamin D therapy market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitamin d therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Vitamin D Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=8810&type=smp

Browse Through More Reports Similar to the Global Vitamin D Therapy Market 2026, By The Business Research Company

Vitamin D Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report

Vitamin D Market Report 2026

https://www.thebusinessresearchcompany.com/report/vitamin-d-global-market-report

Vitamins Market Report 2026

https://www.thebusinessresearchcompany.com/report/vitamins-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795